Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET

Dermapharm Holding SE Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Dermapharm Holding SE stock has a consensus rating of "Buy" and an average price target of €51.00. The average 1-year stock price forecast is 33.16% higher than the current stock price, while the lowest is €44.00 (+14.88%) and the highest is €60.00 (+56.66%).

Price Target: €51.00 (+33.16%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€44.00€51.00€50.00€60.00
Change+14.88%+33.16%+30.55%+56.66%

Analyst Ratings

The average analyst rating for Dermapharm Holding SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Aug '26
Strong Buy222222
Buy222112
Hold222332
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Hold
Maintains
€44.00
HoldMaintains€44.00+14.88%Sep 1, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
€60.00
BuyMaintains€60.00+56.66%Aug 27, 2026

Financial Forecast

Revenue This Year
1.21B
from 1.17B
Increased by 3.66%
Revenue Next Year
1.25B
from 1.21B
Increased by 3.80%
EPS This Year
2.61
from 2.56
Increased by 2.26%
EPS Next Year
2.97
from 2.61
Increased by 13.56%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
943.40M1.03B1.14B1.18B1.17B1.21B
Revenue Growth
18.74%8.65%10.81%4.03%-1.32%3.66%
Gross Profit
593.54M633.18M689.18M735.91M753.25M811.85M
Gross Margin
62.91%61.77%60.68%62.29%64.61%67.18%
Operating Income
295.91M282.72M193.16M222.07M236.62M249.29M
Net Income
209.58M134.24M62.37M113.79M132.41M137.25M
EPS
----2.562.61
EPS Growth
----16.46%2.26%
Forward PE
22.2710.6117.4416.6615.9414.66
Dividend / Share
2.171.050.880.900.881.02
Dividend Growth
146.59%-51.61%-16.19%2.27%-2.22%15.93%
Free Cash Flow
127.86M218.88M106.43M99.52M100.96M153.30M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High1.2B
Avg1.2B
Low1.2B

Revenue Growth

Revenue Growth202620272028
High
5.8%
Avg
3.7%
Low
2.6%

EPS Forecast

EPS202620272028
High2.78
Avg2.61
Low2.43

EPS Growth

EPS Growth202620272028
High
8.7%
Avg
2.3%
Low
-4.9%